Explore
Janux Therapeutics IncJANX
$10.40-2.94%24H
JANX / USDNASDAQ
Use arrow keys to change the interval
Equity Info
P/E Ratio—
Market Cap$758.06M
EPS-1.59
52 Week Range$10.40 - $35.34
Volume$4.19M
Liquidity Score—
About Janux Therapeutics Inc

Janux Therapeutics, Inc., a biopharmaceutical company, develops therapies based on the patented Tumor Activated T Cell Engager (TRACTr) platform technology to treat cancer patients. The company is headquartered in La Jolla, California.

HeadquartersSAN DIEGO, CA

Buy

—
—

Assets

Asset
Janux Therapeutics
rJANX
Reality Finance
Trending
NVDA
NVIDIA Corporation
$151.242.71%
Details
SPY
SPDR S&P 500 ETF Trust
$730.630.24%
Details
QQQ
Invesco QQQ Trust Series 1
$658.950.30%
Details

Help